Trifolium’s essence is centred on problem solving through innovative solutions that make a demonstrable improvement and change for the end user.
We have an enviable position of supporting new product entry to market – supporting innovation through:
Our current product portfolio includes:
Our team has developed an extensive marketing plan for an American client to bring an exciting medical device to the UK and European market.
The device utilises cranial nerve stimulation to enhance neuroplasticity in the brain, effectively ‘re-wiring’ nerve pathways to improve symptoms and function in Traumatic brain Injury. Other indications will follow.
Working with our Israeli colleagues at Saliwell, Trifolium is the sole agent for promoting and selling the Salipen medical device into the UK and Ireland.
Salipen is a device which stimulates the salivary glands to produce natural saliva. Xerostomia or ‘dry mouth’ is a very common problem and causes distressing problems with speaking, eating and swallowing. It is responsible for a high proportion of dental caries and gum disease.
BioMech ACT (Active Contact Tracing) enables an organisation to support its workforce with an Active Contact Tracing System using latest Bluetooth technology and real-time reporting to demonstrate potential areas of concern and manage risks to prevent the spread of Covid.
Sensor technology enables proximity and time-based monitoring. The data collected provides risk-focused reporting based on the wearing of the sensors and interaction between users.